Page last updated: 2024-11-12

fenprostalene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

fenprostalene: RN given refers to (1R*,2R*,3R*,5S*)-(E)-(3R*)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11101484
SCHEMBL ID564040
MeSH IDM0117397

Synonyms (5)

Synonym
69381-94-8
fenprostalene
SCHEMBL564040
methyl (e)-7-(3,5-dihydroxy-2-(3-hydroxy-4-phenoxybut-1-en-1-yl)cyclopentyl)hepta-4,5-dienoate
DTXSID501021614

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with fenprostalene (groups 2 and 3) decreased the number of cows with a palpable uterine lumen detectable during per rectal palpation at 28 to 42 days after parturition."( Evaluation of the use of intrauterine infusions of oxytetracycline, subcutaneous injections of fenprostalene, or a combination of both, for the treatment of retained fetal membranes in dairy cows.
Cattell, MB; Dinsmore, RP; Stevens, RD, 1995
)
0.85

Toxicity

ExcerptReferenceRelevance
"5 microg/kg of fenprostalene can alleviate side effects following fenprostalene administration and have no adverse effect on the survival of newborn puppies, indicating that this method is a reliable and safe way of inducing parturition in bitches."( Induction of parturition in bitches with minimal side effects by two injections of a low dose of fenprostalene, a prostaglandin F2alpha analogue, and pretreatment with prifinium bromide.
Iseki, H; Maruyama, Y; Moriyoshi, M; Nakada, K; Nakao, T, 1999
)
0.87

Pharmacokinetics

ExcerptReferenceRelevance
" As part of the approval process for that indication, pharmacokinetic characteristics of the absorption and elimination of fenprostalene and the depletion of drug residues from the principal edible tissues of swine were studied."( Pharmacokinetic and tissue residue characteristics of fenprostalene, a prostaglandin F2 alpha analog, in swine.
Bowen, JL; Donahue, DJ; Spires, HR; Tomlinson, RV, 1990
)
0.73

Bioavailability

ExcerptReferenceRelevance
" Differences in the molecular structure, formulation, and route of injection of fenprostalene resulted in a slower rate of absorption and elimination of this analog than previously reported for other prostaglandin products."( Absorption and elimination of a prostaglandin F analog, fenprostalene, in lactating dairy cows.
Bowen, JL; Spires, HR; Tomlinson, RV, 1985
)
0.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (56.67)18.7374
1990's10 (33.33)18.2507
2000's3 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.82 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (12.90%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (6.45%)4.05%
Observational0 (0.00%)0.25%
Other25 (80.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]